Vyome Holdings, Inc. (HIND)
NASDAQ: HIND · Real-Time Price · USD
5.01
-0.08 (-1.57%)
At close: Dec 5, 2025, 4:00 PM EST
5.08
+0.07 (1.40%)
After-hours: Dec 5, 2025, 7:59 PM EST
Vyome Holdings Employees
As of December 31, 2024, Vyome Holdings had 18 total employees, including 17 full-time and 1 part-time employees.
Employees
18
Change
n/a
Growth
n/a
Revenue / Employee
$19,144
Profits / Employee
-$519,061
Market Cap
28.28M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 18 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
HIND News
- 11 days ago - Vyome Appoints Renowned Medical Oncologist, Dr. Aditya Bardia, as Senior Medical Advisor to Guide the Development of MFW Program - Business Wire
- 18 days ago - Vyome Holdings Announces Transformational First Quarter Following Nasdaq Listing - Business Wire
- 4 weeks ago - Biomarker Deals Accelerate: Strategic Alliances Reshape Life Sciences Innovation - GlobeNewsWire
- 4 weeks ago - Vyome Holdings Announces Results of Annual Shareholder Meeting - Business Wire
- 2 months ago - Vyome Holdings Acquires MIT AI Spinout Oculo Health - Business Wire
- 2 months ago - Vyome Presents Strong Data Showing Topical VT-1908 is an Effective Treatment for Uveitis, Opening Up a $3B Addressable Market Opportunity - Business Wire
- 3 months ago - Vyome Holdings Strengthens Leadership Team with Industry Veterans as it plans Pivotal Trial Studies - Business Wire
- 3 months ago - Vyome Holdings Announces Positive Interim Data from Phase 2 Study of VT-1953 in Malignant Fungating Wounds (MFW) and Provides Update on MFW market opportunity - Business Wire